Sanofi-Aventis Hits Trail Blazing 42 Percent Growth In April As Indian Drug Market Sprints By 24 Percent
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - June is a keenly awaited month for large and small pharmaceutical companies operating in India as it signals the onset of a long spell of the monsoon season bringing in the rains and effectively meaning peak sales for drug companies riding on the surge in demand in a broad range of anti-infective and common cold and cough drugs